Tenon Medical Announces Board and Officer Changes
Ticker: TNONW · Form: 8-K · Filed: Aug 27, 2024 · CIK: 1560293
| Field | Detail |
|---|---|
| Company | Tenon Medical, Inc. (TNONW) |
| Form Type | 8-K |
| Filed Date | Aug 27, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.001, $315,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, officer-appointment, board-election, compensation
Related Tickers: TNON
TL;DR
Tenon Medical shakes up leadership and compensation - board changes and new officers appointed.
AI Summary
On August 27, 2024, Tenon Medical, Inc. filed an 8-K report detailing changes in its board of directors and executive officers. The filing includes information on the election of new directors and the appointment of certain officers, along with details regarding their compensatory arrangements. The report also covers other events and financial statement disclosures.
Why It Matters
Changes in a company's leadership and compensation structures can signal shifts in strategy or financial health, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in directors and officers, especially if accompanied by new compensation arrangements, can indicate internal restructuring or strategic shifts that may carry inherent risks.
Key Players & Entities
- Tenon Medical, Inc. (company) — Registrant
- August 27, 2024 (date) — Date of earliest event reported
FAQ
What specific changes were made to Tenon Medical's board of directors?
The filing indicates the election of directors, but specific names and the exact number of changes are detailed within the full report.
Who were the newly appointed officers at Tenon Medical?
The report mentions the appointment of certain officers and their compensatory arrangements, with specific details to be found in the full document.
What is the nature of the compensatory arrangements for the new officers?
The filing states that compensatory arrangements for certain officers are disclosed, but the specifics of these arrangements are not provided in the summary.
Are there any financial statement updates included in this 8-K filing?
Yes, the filing indicates that financial statements and exhibits are included as part of the report.
What is the primary reason for this 8-K filing?
This 8-K filing is primarily to report the departure of directors or certain officers, the election of directors, the appointment of certain officers, and their compensatory arrangements, along with other events and financial disclosures.
Filing Stats: 943 words · 4 min read · ~3 pages · Grade level 9.8 · Accepted 2024-08-27 16:13:29
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share TNON The Nasdaq Stock Mar
- $315,000 — any will pay Mr. Williamson a salary of $315,000 per year (the "Base Salary"). In additi
Filing Documents
- ea0212316-8k_tenon.htm (8-K) — 41KB
- ea021231601ex10-1_tenon.htm (EX-10.1) — 21KB
- ea021231601ex99-1_tenon.htm (EX-99.1) — 8KB
- ex10-1_001.jpg (GRAPHIC) — 3KB
- 0001213900-24-072982.txt ( ) — 297KB
- tnon-20240827.xsd (EX-101.SCH) — 4KB
- tnon-20240827_def.xml (EX-101.DEF) — 26KB
- tnon-20240827_lab.xml (EX-101.LAB) — 36KB
- tnon-20240827_pre.xml (EX-101.PRE) — 25KB
- ea0212316-8k_tenon_htm.xml (XML) — 5KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: August 27, 2024 TENON MEDICAL, INC. By: /s/ Steven M. Foster Name: Steven M. Foster Title: Chief Executive Officer and President 2